0102030405
Recombinant Human IL-12 Protein
Product Overview
Recombinant Human Interleukin-12 (IL-12) is a potent cytokine composed of two subunits, p35 and p40, that plays a crucial role in the regulation of immune responses. IL-12 is pivotal in promoting the differentiation of naive T cells into Th1 cells, enhancing the cytotoxic activity of natural killer (NK) cells, and stimulating the production of interferon-gamma (IFN-γ). This protein is essential for research in immunology, oncology, and infectious diseases.
Key Features
1.High Purity: Purified using advanced chromatographic techniques, this product achieves a purity level of over 95%, ensuring accurate and reproducible experimental results.
2.High Biological Activity: Validated through multiple activity assays, this IL-12 protein effectively promotes T cell differentiation and NK cell activity, making it suitable for a range of research applications.
3.Batch Consistency: Produced under stringent quality control measures to ensure high consistency between batches, reducing variability and enhancing experimental reliability.
4.Animal-Free: Manufactured without the use of animal-derived components, adhering to animal-free standards and broadening its applicability for diverse research needs.
Applications
• Immunology Research: Study the role of IL-12 in the regulation of immune responses, including the differentiation of T cells and the activation of NK cells, providing insights into immune mechanisms and potential therapeutic targets.
• Oncology: Explore the effects of IL-12 on tumor immunity, including its ability to enhance the cytotoxic activity of immune cells against cancer cells, contributing to the development of immunotherapeutic approaches.
• Infectious Diseases: Investigate the role of IL-12 in host defense mechanisms against infections, offering valuable information for the development of new treatments for infectious diseases.
• Vaccine Development: Utilize IL-12 in the design and testing of vaccines to enhance immune responses and improve vaccine efficacy.
Specifications and Packaging
• Specifications: Available in various sizes to meet different experimental requirements, including 10μg, 50μg, 100μg, and 1mg.
• Packaging: Supplied in sterile lyophilized form to ensure stability and facilitate convenient storage and transportation.
Storage and Stability
• Storage: Store at -20°C or below to maintain product stability and biological activity. Avoid repeated freeze-thaw cycles to prevent degradation.
• Stability: Stable for long-term storage under recommended conditions, ensuring reliable performance in research applications.
Instructions for Use
1.Dissolve the lyophilized powder in an appropriate sterile buffer in a sterile environment before use.
2.Prepare and dilute the solution according to experimental requirements to ensure accurate and reproducible results.
3.Avoid mixing with other similar products to prevent cross-reactivity and potential interference.
Cautions
• This product is intended for research use only and is not suitable for clinical diagnostics or therapeutic applications.
• Handle the product according to provided instructions to preserve protein activity and integrity.
• For any issues or inquiries regarding the product, please contact our technical support team.

Cytokines | |
Expression Host | HEK293 cells |
Synonym | IL12, p70, Interleukin-12 |
Protein Sequence | Recombinant human IL-12 is heterodimeric and composed of P29459-1 (IL12A) and P29460-1 (IL12B). |
Molecular Mass | The Recombinant Human IL-12 Protein predicts a molecular mass of 65 kDa. |
QC Testing Purity | > 90 % as determined by SDS-PAGE. |
Endotoxin | < 0.1EU per 1 μg of the protein by the LAL method. |
Activity | Measured by cell proliferation assay on PHA activated PBMC cells.The ED50 of this effect is ≤ 0.2 ng/mL. |
Formulation | Lyophilized from sterile PBS, pH 7.4. Normally 6 % mannitol are added as protectants before lyophilization. |
Stability | 24 months at 2℃ to 8℃ in lyophilized state. 6 months at -20℃ under sterile conditions after reconstitution. 12 months at -80℃ under sterile conditions after reconstitution. |
Storage | Recommend to aliquot the protein into smaller quantities after reconstituting with water for injection, normal saline or PBS, and keep the diluted concentration above 100μg/mL. Avoid repeated freeze-thaw cycles. |
Thumb | File information |
![]() |
GMP-TL906_Product Sheet.pdf |
![]() |
GMP-TL906_SDS.pdf |